cytotoxic drug

常見例句

• Pathological change is chronic and continual advancement,patients can emerge renal inadequacy,uraemia.excitatory autacoid and cytotoxic drug have bad curative effect and major adverse reaction.
  病變呈慢性的進(jìn)行性發(fā)展，可逐漸出現(xiàn)腎功能不全、尿毒癥。激素、細(xì)胞毒類藥物療效欠佳，且有較大的不良反應(yīng)。
• Adriamycin is frequently used in combination chemotherapy regiments with other cytotoxic drugs.
  阿霉素常與其他細(xì)胞毒藥物合用于化療方案。
• The mechanism by which chronic-phase CML cells become resistant to conventional cytotoxic drugs, such as hydroxyurea, is unknown.
  慢性期CML細(xì)胞對常規(guī)細(xì)胞毒藥物，如羥基脲產(chǎn)生抗藥性的機(jī)理還不清楚。
• Antibody-drug conjugates enhance the antitumor effects of antibodies and reduce adverse systemic effects of potent cytotoxic drugs.
  抗體偶聯(lián)藥物能提高抗體的抗腫瘤能力并減少有效細(xì)胞毒性藥物的系統(tǒng)性副作用。
• The most effective cytotoxic drugs for treatment of metastatic breast cancer are capecitabine, doxorubicin, gemcitabine, the taxanes paclitaxel and docetaxel, and vinorelbine.
  治療轉(zhuǎn)移性乳腺癌的最有效細(xì)胞毒類藥有卡培他濱、阿霉素、二氟脫氧胞嘧啶、紫杉烷類（紫杉醇和紫杉萜[泰素帝]）、長春瑞濱等。
• Objective To investigate the impacts of cytotoxic drugs on APE/ref-1 expression in A549 cell, in order to find the potential relationship between APE/ref-1 and chemoresistance of NSCLC.
  目的 研究細(xì)胞毒性藥物對A549細(xì)胞APE/ref-1表達(dá)的影響,初步探討APE/ref-1與NSCLC耐藥性產(chǎn)生的相關(guān)性。
返回 cytotoxic drug